3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
2
Anatomic Stage II Breast Cancer AJCC v8
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Multiple Myeloma
1
Melanoma
1
Malignant Solid Neoplasm
1
Lymphoma
1
Lung Neoplasms
1
Hematologic Neoplasms
1
Glioma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Anatomic Stage IV Breast Cancer AJCC v8
1
Anatomic Stage I Breast Cancer AJCC v8
1
Interventions
Cyclophosphamide
48
fludarabine
32
Methotrexate
26
blinatumomab
20
Dexamethasone
20
fludarabine phosphate
19
Vincristine
19
Whole-Body Irradiation
17
Specimen Handling
17
Cytarabine
17
Tacrolimus
15
Peripheral Blood Stem Cell Transplantation
14
Mycophenolic Acid
14
Melphalan
13
Calcium Dobesilate
12
Busulfan
12
Biopsy
12
merphos
11
Mercaptopurine
11
Stem Cell Transplantation
10
Granulocyte Colony-Stimulating Factor
10
Etoposide
10
Cyclosporine
10
Thiotepa
9
Rituximab
9
Magnetic Resonance Spectroscopy
9
Doxorubicin
9
venetoclax
8
ponatinib
8
dexamethasone acetate
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
2C4 antibody
×
90 days
×
Clear all
No trials found.